212 related articles for article (PubMed ID: 28579221)
1. STAT3 in cancer: A double edged sword.
Avalle L; Camporeale A; Camperi A; Poli V
Cytokine; 2017 Oct; 98():42-50. PubMed ID: 28579221
[TBL] [Abstract][Full Text] [Related]
2. Nucleus, Mitochondrion, or Reticulum? STAT3 à La Carte.
Avalle L; Poli V
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30231582
[TBL] [Abstract][Full Text] [Related]
3. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
[TBL] [Abstract][Full Text] [Related]
4. Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein.
Fletcher S; Drewry JA; Shahani VM; Page BD; Gunning PT
Biochem Cell Biol; 2009 Dec; 87(6):825-33. PubMed ID: 19935868
[TBL] [Abstract][Full Text] [Related]
5. STAT3: a multifaceted oncoprotein.
Guanizo AC; Fernando CD; Garama DJ; Gough DJ
Growth Factors; 2018 Apr; 36(1-2):1-14. PubMed ID: 29873274
[TBL] [Abstract][Full Text] [Related]
6. A perylene derivative regulates HIF-1α and Stat3 signaling pathways.
Chen H; Guan Y; Yuan G; Zhang Q; Jing N
Bioorg Med Chem; 2014 Feb; 22(4):1496-505. PubMed ID: 24485121
[TBL] [Abstract][Full Text] [Related]
7. Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment.
Kim BH; Yi EH; Ye SK
Arch Pharm Res; 2016 Aug; 39(8):1085-99. PubMed ID: 27515050
[TBL] [Abstract][Full Text] [Related]
8. Effect of STAT3 inhibition on the metabolic switch in a highly STAT3-activated lymphoma cell line.
Akiyama Y; Iizuka A; Kume A; Komiyama M; Urakami K; Ashizawa T; Miyata H; Omiya M; Kusuhara M; Yamaguchi K
Cancer Genomics Proteomics; 2015; 12(3):133-42. PubMed ID: 25977172
[TBL] [Abstract][Full Text] [Related]
9. Multiple regulation pathways and pivotal biological functions of STAT3 in cancer.
Yuan J; Zhang F; Niu R
Sci Rep; 2015 Dec; 5():17663. PubMed ID: 26631279
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of Stat3 in melanoma: reprogramming the immune microenvironment as an anticancer therapeutic strategy.
Emeagi PU; Maenhout S; Dang N; Heirman C; Thielemans K; Breckpot K
Gene Ther; 2013 Nov; 20(11):1085-92. PubMed ID: 23804077
[TBL] [Abstract][Full Text] [Related]
11. The role of understudied post-translational modifications for the behavior and function of Signal Transducer and Activator of Transcription 3.
Diallo M; Herrera F
FEBS J; 2022 Oct; 289(20):6235-6255. PubMed ID: 34235865
[TBL] [Abstract][Full Text] [Related]
12. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment.
Ren C; Cheng X; Lu B; Yang G
Eur J Cancer; 2013 Dec; 49(18):3889-99. PubMed ID: 23953057
[TBL] [Abstract][Full Text] [Related]
13. Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser⁷²⁷ on STAT3 in prostate cancer cells.
Hsu FN; Chen MC; Lin KC; Peng YT; Li PC; Lin E; Chiang MC; Hsieh JT; Lin H
Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E975-86. PubMed ID: 23941877
[TBL] [Abstract][Full Text] [Related]
14. Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten.
Barbieri I; Pensa S; Pannellini T; Quaglino E; Maritano D; Demaria M; Voster A; Turkson J; Cavallo F; Watson CJ; Provero P; Musiani P; Poli V
Cancer Res; 2010 Mar; 70(6):2558-67. PubMed ID: 20215508
[TBL] [Abstract][Full Text] [Related]
15. Perspectives Regarding the Intersections between STAT3 and Oxidative Metabolism in Cancer.
Chun KS; Jang JH; Kim DH
Cells; 2020 Sep; 9(10):. PubMed ID: 33003453
[TBL] [Abstract][Full Text] [Related]
16. Analysis of STAT3 post-translational modifications (PTMs) in human prostate cancer with different Gleason Score.
Cocchiola R; Romaniello D; Grillo C; Altieri F; Liberti M; Magliocca FM; Chichiarelli S; Marrocco I; Borgoni G; Perugia G; Eufemi M
Oncotarget; 2017 Jun; 8(26):42560-42570. PubMed ID: 28489571
[TBL] [Abstract][Full Text] [Related]
17. Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor.
Alvarez JV; Greulich H; Sellers WR; Meyerson M; Frank DA
Cancer Res; 2006 Mar; 66(6):3162-8. PubMed ID: 16540667
[TBL] [Abstract][Full Text] [Related]
18. STAT3 Interactors as Potential Therapeutic Targets for Cancer Treatment.
Laudisi F; Cherubini F; Monteleone G; Stolfi C
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29914167
[TBL] [Abstract][Full Text] [Related]
19. Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling.
Sanchez-Lopez E; Flashner-Abramson E; Shalapour S; Zhong Z; Taniguchi K; Levitzki A; Karin M
Oncogene; 2016 May; 35(20):2634-44. PubMed ID: 26364612
[TBL] [Abstract][Full Text] [Related]
20. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
